NCT01906164View on ClinicalTrials.gov

Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Respiratory Syncytial Virus Infections
Interventions
DRUG

ALS-008176

DRUG

Placebo

Trial Locations (1)

Unknown

Investigational Site, Rennes

Sponsors
All Listed Sponsors
lead

Alios Biopharma Inc.

INDUSTRY